DYNAVAX TECHNOLOGIES CORP COM USD0.001DYNAVAX TECHNOLOGIES CORP COM USD0.001DYNAVAX TECHNOLOGIES CORP COM USD0.001

DYNAVAX TECHNOLOGIES CORP COM USD0.001

No trades
See on Supercharts

0IDA fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

0IDA does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company